Ginsenoside Compound K Mitigates Mitochondrial Fission Through Bile Acid Receptors/YAP Signaling to Counteract Podocyte Injury in Lupus Nephritis
- PMID: 40528637
- DOI: 10.1002/ptr.8492
Ginsenoside Compound K Mitigates Mitochondrial Fission Through Bile Acid Receptors/YAP Signaling to Counteract Podocyte Injury in Lupus Nephritis
Abstract
Irreversible renal damage in lupus nephritis (LN) results from critical podocyte injury. Disruption in the actin cytoskeleton initiates mitochondrial fission to exacerbate podocyte injury. While ginsenoside compound K (CK) alleviates podocyte injury in lupus-prone mice, its mechanism in regulating mitochondrial dynamics underlying remains elusive. Based on the open-source single-cell RNA sequencing dataset, this study clarified CK's role in alleviating podocyte injury in MRL/lpr mice by regulating cytoskeleton-mediated mitochondrial fission and elucidated the molecular mechanisms underlying the BA receptor-YAP axis. MRL/lpr mice were administered CK (20 or 40 mg/kg) for 10 weeks. Renal function and pathological changes were evaluated, along with renal metabolite profiles and metabolomics analysis. We analyzed publicly available single-cell RNA sequencing data to specifically profile gene mapping and enrichment analysis during immune-mediated renal injury. Furthermore, podocyte-based in vitro assays were conducted to investigate the impact of the BA receptors-YAP axis on mitochondrial dynamics. CK effectively cleared anti-dsDNA antibodies, attenuated systemic inflammation, and improved renal function through resolving immune complex deposition. Mechanistically, CK restored actin cytoskeleton integrity via Rho GTPase regulation and reshaped BA metabolism to activate TGR5/FXR receptors in podocytes. This dual action suppressed DRP1 s616 phosphorylation, inhibiting excessive mitochondrial fission, regulating while enhancing TFAM-mediated mtDNA replication for mitochondrial homeostasis. Concurrently, CK attenuated podocyte apoptosis through Hippo signaling inhibition and YAP activation. In conclusion, CK ameliorates podocyte injury by preventing excessive mitochondrial fission through the BA receptors-YAP axis, thus providing a potential therapy for LN.
Keywords: bile acid receptor; ginsenoside compound K; lupus nephritis; mitochondrial dynamics; podocyte.
© 2025 John Wiley & Sons Ltd.
Similar articles
-
Reciprocal regulation of SIRT1 and AMPK by Ginsenoside compound K impedes the conversion from plasma cells to mitigate for podocyte injury in MRL/lpr mice in a B cell-specific manner.J Ginseng Res. 2024 Mar;48(2):190-201. doi: 10.1016/j.jgr.2023.11.006. Epub 2023 Dec 3. J Ginseng Res. 2024. PMID: 38465215 Free PMC article.
-
C5a-C5aR1 axis controls mitochondrial fission to promote podocyte injury in lupus nephritis.Mol Ther. 2024 May 1;32(5):1540-1560. doi: 10.1016/j.ymthe.2024.03.003. Epub 2024 Mar 6. Mol Ther. 2024. PMID: 38449312 Free PMC article.
-
Fasudil compensates podocyte injury via CaMK4/Rho GTPases signal and actin cytoskeleton-dependent activation of YAP in MRL/lpr mice.Int Immunopharmacol. 2023 Jun;119:110199. doi: 10.1016/j.intimp.2023.110199. Epub 2023 Apr 24. Int Immunopharmacol. 2023. PMID: 37094544
-
Unraveling the podocyte injury in lupus nephritis: Clinical and experimental approaches.Semin Arthritis Rheum. 2017 Apr;46(5):632-641. doi: 10.1016/j.semarthrit.2016.10.005. Epub 2016 Oct 17. Semin Arthritis Rheum. 2017. PMID: 27839739 Review.
-
Immune podocytes in the immune microenvironment of lupus nephritis (Review).Mol Med Rep. 2023 Nov;28(5):204. doi: 10.3892/mmr.2023.13091. Epub 2023 Sep 15. Mol Med Rep. 2023. PMID: 37711069 Free PMC article. Review.
References
-
- Ayanga, B. A., S. S. Badal, Y. Wang, et al. 2016. “Dynamin‐Related Protein 1 Deficiency Improves Mitochondrial Fitness and Protects Against Progression of Diabetic Nephropathy.” Journal of the American Society of Nephrology 27, no. 9: 2733–2747. https://doi.org/10.1681/ASN.2015101096.
-
- Bidula, S., K. Dhuna, R. Helliwell, and L. Stokes. 2019. “Positive Allosteric Modulation of P2X7 Promotes Apoptotic Cell Death Over Lytic Cell Death Responses in Macrophages.” Cell Death & Disease 10, no. 12: 882. https://doi.org/10.1038/s41419‐019‐2110‐3.
-
- Bonneaud, T. L., C. C. Lefebvre, L. Nocquet, et al. 2022. “Targeting of MCL‐1 in Breast Cancer‐Associated Fibroblasts Reverses Their Myofibroblastic Phenotype and Pro‐Invasive Properties.” Cell Death & Disease 13, no. 9: 787. https://doi.org/10.1038/s41419‐022‐05214‐9.
-
- Caielli, S., S. Athale, B. Domic, et al. 2016. “Oxidized Mitochondrial Nucleoids Released by Neutrophils Drive Type I Interferon Production in Human Lupus.” Journal of Experimental Medicine 213, no. 5: 697–713. https://doi.org/10.1084/jem.20151876.
-
- Campbell, K. J., S. M. Mason, M. L. Winder, et al. 2021. “Breast Cancer Dependence on MCL‐1 Is due to Its Canonical Anti‐Apoptotic Function.” Cell Death and Differentiation 28, no. 9: 2589–2600. https://doi.org/10.1038/s41418‐021‐00773‐4.
Grants and funding
- 2025KY971/the Health and Family Planning Commission of Zhejiang Province
- GZS2021021/the Tangjun Famous Traditional Chinese Medicine Doctor Inherit Workstation Project of Zhejiang Province of China
- 2D02311/the Advantage Discipline Construction Project from Zhejiang Provincial Hospital of Traditional Chinese Medicine
- GZS2020021/the Huangqi Famous Traditional Chinese Medicine Doctor Inherit Workstation Project of Zhejiang Province of China
- 2020ZZ009/the Project of Zhejiang Provincial Administration of Traditional Chinese Medicine
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous